Production of recombinant immunotherapeutics for anticancer treatment: the role of bioengineering.
about
CAR-modified T-cell therapy for cancer: an updated review.A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccinesBioengineered non-coding RNA agent (BERA) in action.Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges.Recombinant Immunotoxin Therapy of Solid Tumors: Challenges and Strategies.
P2860
Production of recombinant immunotherapeutics for anticancer treatment: the role of bioengineering.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Production of recombinant immu ...... t: the role of bioengineering.
@en
Production of recombinant immu ...... t: the role of bioengineering.
@nl
type
label
Production of recombinant immu ...... t: the role of bioengineering.
@en
Production of recombinant immu ...... t: the role of bioengineering.
@nl
prefLabel
Production of recombinant immu ...... t: the role of bioengineering.
@en
Production of recombinant immu ...... t: the role of bioengineering.
@nl
P2860
P356
P1433
P1476
Production of recombinant immu ...... t: the role of bioengineering.
@en
P2093
Maria-Cristina S Pranchevicius
Thiessa R Vieira
P2860
P304
P356
10.4161/BIOE.24666
P577
2013-04-22T00:00:00Z